The Impact of Telemedicine for Monitoring and Treatment of Phenylketonuria Patients on Metabolic Outcome During Coronavirus Disease-19 Outbreak.


Creative Commons License

Zubarioglu T., Hopurcuoglu D. , Uygur E., Ahmadzada S., Oge-Enver E., Isat E., ...Daha Fazla

Telemedicine journal and e-health : the official journal of the American Telemedicine Association, 2021 (SCI Expanded İndekslerine Giren Dergi) identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası:
  • Basım Tarihi: 2021
  • Doi Numarası: 10.1089/tmj.2020.0569
  • Dergi Adı: Telemedicine journal and e-health : the official journal of the American Telemedicine Association

Özet

Background: The prognosis of phenylketonuria (PKU) in terms of neurocognitive outcome is directly related to lifelong phenylalanine (Phe) levels and adherence to treatment. Monitoring and treatment of PKU patients can be complicated in challenging circumstances as pandemics. This study aims to evaluate the impact of telemedicine for monitoring and treatment of PKU patients on metabolic outcome during coronavirus disease-19 (COVID-19) outbreak.